Florida has become the second U.S. state to ban fluoride in its public water systems, following a controversial trend among Republican-led states. Governor Ron DeSantis signed the legislation on Thursday, calling the addition of fluoride to tap water “forced medication.” The ban takes effect on July 1.
Fluoride, a naturally occurring mineral found in water, soil, and air, has been widely used for decades to prevent cavities and strengthen teeth. About 63% of Americans currently receive fluoridated water, according to the CDC. Public health organizations, including the American Dental Association (ADA), argue that fluoridation significantly improves dental health and poses no proven harm. However, fluoride has faced growing political opposition, especially from figures like DeSantis and Health Secretary Robert F. Kennedy Jr., who link it to health risks such as cancer and reduced cognitive function in children—claims the American Cancer Society says lack strong evidence.
DeSantis, who previously opposed public health mandates during the COVID-19 pandemic, said medical experts “shouldn’t be able to decree how we live our lives,” criticizing what he sees as overreach by health authorities.
Utah became the first state to enact a similar ban in March. Meanwhile, the FDA is currently reviewing the safety of fluoride supplements for children, signaling broader scrutiny of the mineral’s use in public health.
The ADA strongly opposes these moves, urging a thorough review before policy changes are made. President Brett Kessler emphasized the need to “slow down” and fully assess the implications of banning fluoride for national health.
The fluoride debate is intensifying as Republican states challenge long-standing public health practices, raising questions about science, personal choice, and government intervention in health policy.


FAA Unveils Flight Plan 2026 to Strengthen Aviation Safety and Workforce Development
Major Drugmakers Slash U.S. Prices and Sell Directly to Patients Amid Trump’s Push for Affordable Medicines
Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market
Federal Judge Declines to Immediately Halt Trump’s $300 Million White House Ballroom Project
Trump Administration Unveils High-Priced “Trump Gold Card” Visa Program
Sydney Bondi Beach Terror Attack Kills 16, Sparks Gun Law and Security Debate
Eli Lilly’s Weight-Loss Pill Nears Fast-Track FDA Approval as Profits Surge on Global Demand
Novo Nordisk Appoints Greg Miley as Global Head of Corporate Affairs Amid U.S. Pricing Pressure
U.S. Offers NATO-Style Security Guarantees to Ukraine as Peace Talks Show Progress
EU Signals Major Shift on 2035 Combustion Engine Ban Amid Auto Industry Pressure
FDA Memo Raises Questions About Possible COVID-19 Vaccine Links to Rare Child Deaths
Korea Zinc to Build $7.4 Billion Critical Minerals Refinery in Tennessee With U.S. Government Backing
Thousands Protest in Brazil Against Efforts to Reduce Jair Bolsonaro’s Prison Sentence
Bayer’s Stroke Drug Achieves Breakthrough Trial Results, Boosting Market Confidence 



